CCR6 and major depressive disorder: Furthermore, large effect sizes obtained for CCL24 and CCR6 (see Tables 3 and 4, and Results section) in both the discovery and validation studies support the notion that transcription of these genes could strongly differentiate MDD patients from other subject groups, and thus might indeed be useful as biomarkers.